Schedule 13G ownership disclosure
Iovance Biotherapeutics Inc
Security class unavailable · CUSIP: 462260100
Event date: 2018-01-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-040979
- Form type
- SC 13G
- Filer
- IOVANCE BIOTHERAPEUTICS, INC.
- CIK
- CIK 1425205
- Filed
- Feb 14, 2019
- Reporting period
- Jan 29, 2018
- Description
- Schedule 13G beneficial ownership